24 HIV-specific, ex vivo expanded T cell therapy (HXTC) for HIV clearance: feasibility, safety and efficacy

by Julia M. Sung, JoAnnD Kuruc, Matthew Clohosey, Amanda Crooks, Shabnum Patel, Lauren Roesch, Patrick Hanley, CRussell Cruz, Nancie Archin, JosephJ Eron, Nilu Goonetilleke, Cliona M. Rooney, Catherine M. Bollard, David M. Margolis, Cynthia L. Gay
Published 2017-07-01

The HIV-1 latent reservoir is largely sensitive to circulating T cells

by Joanna A Warren, Shuntai Zhou, Yinyan Xu, Matthew J Moeser, Daniel R MacMillan, Olivia Council, Jennifer Kirchherr, Julia M Sung, Nadia R Roan, Adaora A Adimora, Sarah Joseph, JoAnn D Kuruc, Cynthia L Gay, David M Margolis, Nancie Archin, Zabrina L Brumme, Ronald Swanstrom, Nilu Goonetilleke
Published 2020-10-01

Reliable Estimation of CD8 T Cell Inhibition of In Vitro HIV-1 Replication

by Yinyan Xu, Ann Marie Weideman, Ann Marie Weideman, Maria Abad-Fernandez, Katie R. Mollan, Katie R. Mollan, Sallay Kallon, Shahryar Samir, Joanna A. Warren, Genevieve Clutton, Nadia Roan, Nadia Roan, Adaora A. Adimora, Adaora A. Adimora, Adaora A. Adimora, Nancie Archin, JoAnn Kuruc, Cindy Gay, Michael G. Hudgens, Michael G. Hudgens, Nilu Goonetilleke, Nilu Goonetilleke
Published 2021-06-01